However, as the combined use of miR-21, HE4, and CA125 is rarely discussed in existing literature on postoperative recurrence of ovarian cancer, this study focused on the value of serum miR-21, HE4, and CA125 in the surveillance for postoperative recurrence and metastasis of ovarian cancer. This evidence concerns the gene WFDC2 and ovarian cancer.